Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A

Journal of Biological Chemistry

Volumn 287, Issue 32, 2012, Pages 26596-26605

  Ceholski, Delaine K ^a   Trieber, Catharine A ^a   Holmes, Charles F B ^a   Young, Howard S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ENZYMES;

AROMATIC SUBSTITUTIONS; CARDIAC CONTRACTILITY; DILATED CARDIOMYOPATHY; PENTAMERS; PHOSPHOLAMBAN; PROTEIN KINASE; PROTEIN KINASE A; SARCOPLASMIC RETICULUM;

PHOSPHORYLATION;

ARGININE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYSTEINE; HISTIDINE; LEUCINE; MUTANT PROTEIN; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME INHIBITION; GENE DELETION; GENE MUTATION; HEART MUSCLE CONTRACTILITY; HYDROPHOBICITY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION;

EID: 84864535546     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.382713     Document Type: Article

References (50)

1. Tada, M., Kirchberger, M. A., and Katz, A. M. (1976) Regulation of calcium transport in cardiac sarcoplasmic reticulum by cyclic AMP-dependent protein kinase. Recent Adv. Stud. Cardiac Struct. Metab. 9, 225-239
2. Morgan, J. P. (1991) Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N. Engl. J. Med. 325, 625-632
3. Simmerman, H. K., Collins, J. H., Theibert, J. L., Wegener, A. D., and Jones, L. R. (1986) Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261, 13333-13341 (Pubitemid 17006915)
4. Schmidt, A. G., Edes, I., and Kranias, E. G. (2001) Phospholamban. A promising therapeutic target in heart failure? Cardiovasc. Drugs Ther. 15, 387-396 (Pubitemid 34098509)
5. Grünig, E., Tasman, J. A., Kücherer, H., Franz, W., Kübler, W., and Katus, H. A. (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 31, 186-194 (Pubitemid 28064741)
6. Brittsan, A. G., and Kranias, E. G. (2000) Phospholamban and cardiac contractile function. J. Mol. Cell Cardiol. 32, 2131-2139 (Pubitemid 32039765)
7. Luo, W., Wolska, B. M., Grupp, I. L., Harrer, J. M., Haghighi, K., Ferguson, D. G., Slack, J. P., Grupp, G., Doetschman, T., Solaro, R. J., and Kranias, E. G. (1996) Phospholamban gene dosage effects in the mammalian heart. Circ. Res. 78, 839-847 (Pubitemid 26131368)
8. Frank, K. F., Bölck, B., Brixius, K., Kranias, E. G., and Schwinger, R. H. (2002) Modulation of SERCA. Implications for the failing human heart. Basic Res. Cardiol. 97, I72-I78
9. Haghighi, K., Kolokathis, F., Gramolini, A. O., Waggoner, J. R., Pater, L., Lynch, R. A., Fan, G. C., Tsiapras, D., Parekh, R. R., Dorn, G. W., 2nd, MacLennan, D. H., Kremastinos, D. T., and Kranias, E. G. (2006) A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 103, 1388-1393 (Pubitemid 43191175)
10. Haghighi, K., Kolokathis, F., Pater, L., Lynch, R. A., Asahi, M., Gramolini, A. O., Fan, G. C., Tsiapras, D., Hahn, H. S., Adamopoulos, S., Liggett, S. B., Dorn, G. W., 2nd, MacLennan, D. H., Kremastinos, D. T., and Kranias, E. G. (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 111, 869-876 (Pubitemid 37074962)
11. Schmitt, J. P., Kamisago, M., Asahi, M., Li, G. H., Ahmad, F., Mende, U., Kranias, E. G., MacLennan, D. H., Seidman, J. G., and Seidman, C. E. (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410-1413 (Pubitemid 36254657)
12. Medeiros, A., Biagi, D. G., Sobreira, T. J., de Oliveira, P. S., Negrão, C. E., Mansur, A. J., Krieger, J. E., Brum, P. C., and Pereira, A. C. (2011) Mutations in the human phospholamban gene in patients with heart failure. Am. Heart J. 162, 1088-1095
13. Haghighi, K., Schmidt, A. G., Hoit, B. D., Brittsan, A. G., Yatani, A., Lester, J. W., Zhai, J., Kimura, Y., Dorn, G. W., 2nd, MacLennan, D. H., and Kranias, E. G. (2001) Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J. Biol. Chem. 276, 24145-24152
14. Zhai, J., Schmidt, A. G., Hoit, B. D., Kimura, Y., MacLennan, D. H., and Kranias, E. G. (2000) Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J. Biol. Chem. 275, 10538-10544 (Pubitemid 30202118)
15. Zvaritch, E., Backx, P. H., Jirik, F., Kimura, Y., de Leon, S., Schmidt, A. G., Hoit, B. D., Lester, J. W., Kranias, E. G., and MacLennan, D. H. (2000) The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility. J. Biol. Chem. 275, 14985-14991 (Pubitemid 30337216)
16. 2+-ATPase through intramembrane interactions. J. Biol. Chem. 271, 21726-21731
17. Fujii, J., Maruyama, K., Tada, M., and MacLennan, D. H. (1989) Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation. J. Biol. Chem. 264, 12950-12955 (Pubitemid 19194866)
18. Ceholski, D. K., Trieber, C. A., and Young, H. S. (2012) Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy. J. Biol. Chem. 287, 16521-16529
19. Eletr, S., and Inesi, G. (1972) Phospholipid orientation in sarcoplasmic membranes. Spin-label ESR and proton MNR studies. Biochim. Biophys. Acta 282, 174-179
20. Stokes, D. L., and Green, N. M. (1990) Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing. Biophys. J. 57, 1-14 (Pubitemid 20033741)
21. 2+-ATPase regulatory proteins for high-resolution structural studies. Protein Expr. Purif. 40, 118-125
22. Trieber, C. A., Douglas, J. L., Afara, M., and Young, H. S. (2005) The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes. Biochemistry 44, 3289-3297 (Pubitemid 40321999)
23. 2+-ATPase. Ann. N.Y. Acad. Sci. 853, 103-115
24. Warren, G. B., Toon, P. A., Birdsall, N. J., Lee, A. G., and Metcalfe, J. C. (1974) Reconstitution of a calcium pump using defined membrane components. Proc. Natl. Acad. Sci. U.S.A. 71, 622-626
25. Young, H. S., Rigaud, J. L., Lacapère, J. J., Reddy, L. G., and Stokes, D. L. (1997) How to make tubular crystals by reconstitution of detergent-solubilized Ca2+-ATPase. Biophys. J. 72, 2545-2558 (Pubitemid 27227590)
26. 2+-ATPase by cryoelectron microscopy. Biophys. J. 81, 884-894
27. Studier, F. W. (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41, 207-234
28. Hastie, C. J., McLauchlan, H. J., and Cohen, P. (2006) Assay of protein kinases using radiolabeled ATP. A protocol. Nat. Protoc. 1, 968-971
29. Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., and Hasenfuss, G. (1995) Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92, 778-784
30. 2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 75, 434-442
31. Moore, M. J., Adams, J. A., and Taylor, S. S. (2003) Structural basis for peptide binding in protein kinase A. Role of glutamic acid 203 and tyrosine 204 in the peptide-positioning loop. J. Biol. Chem. 278, 10613-10618 (Pubitemid 36800331)
32. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 269, 3088-3094
33. 2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep. 8, 1061-1067
34. Neuberger, G., Schneider, G., and Eisenhaber, F. (2007) pkaPS. Prediction of protein kinase A phosphorylation sites with the simplified kinase-substrate binding model. Biol. Direct 2, 1
35. Masterson, L. R., Cheng, C., Yu, T., Tonelli, M., Kornev, A., Taylor, S. S., and Veglia, G. (2010) Dynamics connect substrate recognition to catalysis in protein kinase A. Nat. Chem. Biol. 6, 821-828
36. Kemp, B. E., Graves, D. J., Benjamini, E., and Krebs, E. G. (1977) Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J. Biol. Chem. 252, 4888-4894 (Pubitemid 8162200)
37. Li, C. F., Wang, J. H., and Colyer, J. (1990) Immunological detection of phospholamban phosphorylation states facilitates the description of the mechanism of phosphorylation and dephosphorylation. Biochemistry 29, 4535-4540 (Pubitemid 20172667)
38. DeWitt, M. M., MacLeod, H. M., Soliven, B., and McNally, E. M. (2006) Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. J. Am. Coll. Cardiol. 48, 1396-1398 (Pubitemid 44436827)
39. Posch, M. G., Perrot, A., Geier, C., Boldt, L. H., Schmidt, G., Lehmkuhl, H. B., Hetzer, R., Dietz, R., Gutberlet, M., Haverkamp, W., and Ozcelik, C. (2009) Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm 6, 480-486
40. Haghighi, K., Pritchard, T., Bossuyt, J., Waggoner, J. R., Yuan, Q., Fan, G. C., Osinska, H., Anjak, A., Rubinstein, J., Robbins, J., Bers, D. M., and Kranias, E. G. (2012) The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase. J. Mol. Cell. Cardiol. 52, 773-782
41. Kho, C., Lee, A., Jeong, D., Oh, J. G., Chaanine, A. H., Kizana, E., Park, W. J., and Hajjar, R. J. (2011) SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477, 601-605
42. 2+-ATPase regulation and phosphorylation by protein kinase A. Proc. Natl. Acad. Sci. U.S.A. 108, 2735-2740
43. Shabb, J. B. (2001) Physiological substrates of cAMP-dependent protein kinase. Chem. Rev. 101, 2381-2411
44. Minamisawa, S., Hoshijima, M., Chu, G., Ward, C. A., Frank, K., Gu, Y., Martone, M. E., Wang, Y., Ross, J., Jr., Kranias, E. G., Giles, W. R., and Chien, K. R. (1999) Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99, 313-322 (Pubitemid 29519910)
45. Kass, D. A., Hare, J. M., and Georgakopoulos, D. (1998) Murine cardiac function. A cautionary tail. Circ. Res. 82, 519-522 (Pubitemid 28117334)
46. del Monte, F., Harding, S. E., Schmidt, U., Matsui, T., Kang, Z. B., Dec, G. W., Gwathmey, J. K., Rosenzweig, A., and Hajjar, R. J. (1999) Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100, 2308-2311
47. Paterlini, M. G., and Thomas, D. D. (2005) The α-helical propensity of the cytoplasmic domain of phospholamban. A molecular dynamics simulation of the effect of phosphorylation and mutation. Biophys. J. 88, 3243-3251 (Pubitemid 40586576)
48. Zamoon, J., Mascioni, A., Thomas, D. D., and Veglia, G. (2003) NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys. J. 85, 2589-2598 (Pubitemid 37210804)
49. Knighton, D. R., Zheng, J. H., Ten Eyck, L. F., Xuong, N. H., Taylor, S. S., and Sowadski, J. M. (1991) Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 414-420 (Pubitemid 21917166)
50. Masterson, L. R., Shi, L., Metcalfe, E., Gao, J., Taylor, S. S., and Veglia, G. (2011) Dynamically committed, uncommitted, and quenched states encoded in protein kinase A revealed by NMR spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 108, 6969-6974